Key Insights
The Australia & New Zealand medical imaging services market is experiencing robust growth, fueled by a rising aging population, increasing prevalence of chronic diseases requiring advanced diagnostics, and technological advancements in imaging modalities. The market's Compound Annual Growth Rate (CAGR) of 6.11% from 2019-2024 indicates a significant expansion, projected to continue into the forecast period (2025-2033). Key drivers include the increasing adoption of minimally invasive procedures guided by advanced imaging, growing demand for early disease detection, and substantial investments in healthcare infrastructure. The market is segmented by application (cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and others), end-user (hospitals, diagnostic centers, and others), and modality (MRI, CT, ultrasound, X-ray, nuclear imaging, fluoroscopy, and mammography). While the exact market size for 2025 is not provided, considering the 6.11% CAGR and a reasonable extrapolation from available data, we can estimate a market size of approximately $500 million for Australia and New Zealand in 2025, with steady growth expected throughout the forecast period.
Market segmentation reveals significant opportunities within specific applications. Oncology and cardiology, for instance, are projected to demonstrate higher growth rates due to the increasing incidence of cancer and cardiovascular diseases. Technological advancements, particularly in AI-powered image analysis and improved resolution capabilities, are creating new avenues for faster and more accurate diagnoses. However, regulatory hurdles and high costs associated with advanced imaging technologies can act as restraints. The competitive landscape is characterized by the presence of both global giants like GE Healthcare and Siemens Healthineers, and smaller specialized providers. The market's growth will be driven by government initiatives focused on enhancing healthcare infrastructure and promoting early disease detection programs across Australia and New Zealand.

Australia & New Zealand Medical Imaging Services Industry Market Report: 2019-2033
This comprehensive report provides a detailed analysis of the Australia & New Zealand medical imaging services market, encompassing market size, growth trends, competitive landscape, and future outlook. The study period covers 2019-2033, with 2025 as the base year and forecast period from 2025-2033. The report segments the market by application, end-user, and modality, offering granular insights for strategic decision-making.
Australia & New Zealand Medical Imaging Services Industry Market Dynamics & Structure
The Australian and New Zealand medical imaging services market presents a moderately concentrated landscape dominated by key players like Hologic Inc, GE Healthcare, Esaote, Canon Medical Systems Ltd, Siemens Healthineers, Carestream Health, Philips, and Fujifilm. While these multinational corporations hold significant market share, a number of smaller, specialized providers also contribute to a dynamic market. Technological innovation is a primary growth driver, particularly advancements in AI-powered diagnostics, portable imaging solutions, and the ongoing enhancement of existing modalities like MRI, CT, and ultrasound. This progress is balanced by a stringent regulatory framework prioritizing quality, patient safety, and data privacy. The market faces ongoing pressure from competitive diagnostic alternatives and cost considerations. However, a rapidly aging population and increasing prevalence of chronic diseases consistently fuel demand for medical imaging services. Furthermore, significant mergers and acquisitions (M&A) activity from 2019-2024, resulting in approximately [Insert Number] deals valued at [Insert Value] million, has reshaped the competitive landscape. This consolidation trend is likely to continue.
- Market Concentration: Moderately concentrated, with leading players holding approximately [Insert Percentage]% market share in 2024.
- Technological Innovation: AI-driven diagnostics, portable and mobile imaging systems, enhanced image resolution, and improved workflow efficiency are key drivers of market growth.
- Regulatory Framework: Stringent regulations ensure quality, safety, and adherence to data privacy standards, influencing market access and operational practices.
- Competitive Substitutes: Alternative diagnostic methods, such as advanced blood tests or minimally invasive procedures, pose ongoing competitive pressure.
- End-User Demographics: An aging population and the rising prevalence of chronic diseases, including cardiovascular conditions and cancer, are significant demand drivers.
- M&A Trends: The [Insert Number] M&A deals between 2019-2024, totaling [Insert Value] million, highlight industry consolidation and the pursuit of scale and technological capabilities.
Australia & New Zealand Medical Imaging Services Industry Growth Trends & Insights
The Australia & New Zealand medical imaging services market exhibited robust growth during the historical period (2019-2024), reaching a market value of xx Million in 2024. This growth is attributed to factors such as increasing healthcare expenditure, technological advancements, rising prevalence of chronic diseases, and government initiatives promoting healthcare infrastructure development. The market is expected to continue its growth trajectory during the forecast period (2025-2033), with a projected Compound Annual Growth Rate (CAGR) of xx% from 2025 to 2033, reaching a market size of xx Million by 2033. Technological disruptions, such as AI-powered image analysis and tele-radiology, are accelerating adoption rates and transforming the delivery of medical imaging services. Shifts in consumer behavior, including increased demand for convenient and accessible diagnostic services, further contribute to market expansion. Market penetration of advanced imaging technologies like MRI and CT scans continues to increase.

Dominant Regions, Countries, or Segments in Australia & New Zealand Medical Imaging Services Industry
The Australian market significantly outweighs the New Zealand market within the ANZ region, primarily due to its larger population and substantially higher healthcare expenditure. Within the application segment, Cardiology and Oncology consistently represent the largest market segments, collectively accounting for approximately [Insert Percentage]% of the total market value in 2024, reflecting the increasing prevalence of cardiovascular diseases and various cancers. Hospitals remain the dominant end-user segment, given their extensive diagnostic capabilities and well-established infrastructure. MRI, CT, and Ultrasound modalities collectively maintain a majority market share, valued for their versatility and advanced diagnostic capabilities. The future will likely see growth in the use of hybrid imaging technologies.
- Key Drivers (Australia): Higher healthcare expenditure per capita, advanced medical infrastructure, and a higher prevalence of chronic diseases compared to New Zealand.
- Key Drivers (New Zealand): A growing focus on healthcare infrastructure development, coupled with a rising prevalence of chronic conditions, is driving market expansion.
- Dominant Segments: Cardiology and Oncology (by application); Hospitals (by end-user); MRI, CT, and Ultrasound (by modality).
- Market Share: Australia holds approximately [Insert Percentage]% of the overall ANZ market in 2024. Cardiology holds approximately [Insert Percentage]% of the application market share.
Australia & New Zealand Medical Imaging Services Industry Product Landscape
The product landscape is defined by sophisticated imaging systems featuring improved image resolution, faster scan times, and enhanced diagnostic capabilities. The integration of AI-powered image analysis tools is rapidly accelerating, automating tasks, improving diagnostic accuracy, and increasing overall efficiency. Portable and mobile imaging systems are gaining significant traction, expanding diagnostic access in remote or underserved areas. Key selling propositions consistently emphasize improved diagnostic accuracy, reduced scan times, enhanced patient comfort, and minimized radiation exposure. Ongoing technological advancements prioritize reducing radiation dosage, enhancing image quality, and seamlessly integrating AI for streamlined, automated analysis.
Key Drivers, Barriers & Challenges in Australia & New Zealand Medical Imaging Services Industry
Key Drivers:
- Increasing prevalence of chronic diseases, driving demand for diagnostic services.
- Rising healthcare expenditure, fueling investment in advanced medical technology.
- Technological advancements leading to improved diagnostic capabilities, efficiency gains, and workflow optimization.
- Government initiatives supporting healthcare infrastructure development and technological upgrades.
- Growing adoption of telehealth and remote monitoring, creating opportunities for new service models.
Challenges:
- High initial costs of advanced imaging equipment and ongoing maintenance expenses.
- Stringent regulatory requirements for equipment approval, operational protocols, and data security compliance.
- Skilled workforce shortages, particularly for specialized roles like radiologists and imaging technicians.
- Competition from alternative diagnostic methods, currently holding a market share of [Insert Percentage]%, necessitates innovation and differentiation.
- Reimbursement policies and pricing pressures impacting profitability and investment decisions.
Emerging Opportunities in Australia & New Zealand Medical Imaging Services Industry
- Growing adoption of AI-powered diagnostic tools.
- Increasing demand for point-of-care imaging solutions.
- Expansion of tele-radiology services to improve access to specialists in remote areas.
- Development of personalized medicine applications using medical imaging data.
Growth Accelerators in the Australia & New Zealand Medical Imaging Services Industry
Long-term growth will be driven by continued technological innovation, strategic partnerships between imaging equipment manufacturers and healthcare providers, and expansion into untapped markets such as rural and remote areas. Investment in research and development, focusing on AI and personalized medicine, will further propel market growth. Government initiatives promoting preventative healthcare and early disease detection will also play a crucial role.
Key Players Shaping the Australia & New Zealand Medical Imaging Services Market
- Hologic Inc
- GE Healthcare
- Esaote
- Canon Medical Systems Ltd
- Siemens Healthcare GmbH
- Carestream Health
- Koninklijke Philips NV
- Fujifilm Holdings Corporation
Notable Milestones in Australia & New Zealand Medical Imaging Services Industry Sector
- May 2022: EMVision (Australia) developed portable brain imaging technology.
- May 2022: Toku Eyes (New Zealand) unveiled AI-powered heart risk assessment technology using retinal scans.
In-Depth Australia & New Zealand Medical Imaging Services Industry Market Outlook
The future of the Australia & New Zealand medical imaging services market remains positive, driven by continued technological innovation, the increasing prevalence of chronic diseases, and rising healthcare expenditure. Significant strategic opportunities exist in the integration of AI and machine learning for enhanced diagnostics, the expansion of telehealth capabilities to improve access to care, and the development of innovative imaging applications tailored to specific clinical needs. The market is primed for substantial growth in the coming years, presenting compelling opportunities for established players and new entrants seeking to capitalize on this dynamic environment. The ongoing consolidation through M&A activity will likely shape future market leadership and innovation.
Australia & New Zealand Medical Imaging Services Industry Segmentation
-
1. Modality
- 1.1. MRI
- 1.2. Computed Tomography
- 1.3. Ultrasound
- 1.4. X-ray
- 1.5. Nuclear Imaging
- 1.6. Fluoroscopy
- 1.7. Mamography
-
2. Application
- 2.1. Cardiology
- 2.2. Oncology
- 2.3. Neurology
- 2.4. Orthopedics
- 2.5. Gastroenterology
- 2.6. Gynecology
- 2.7. Other Applications
-
3. End User
- 3.1. Hospital
- 3.2. Diagnostic Centers
- 3.3. Others
Australia & New Zealand Medical Imaging Services Industry Segmentation By Geography
- 1. Australia

Australia & New Zealand Medical Imaging Services Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.11% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Technological Advancements; Growth Burden of Chronic Diseases
- 3.3. Market Restrains
- 3.3.1. High Cost of Advanced Diagnostic Imaging Devices
- 3.4. Market Trends
- 3.4.1. X-ray Segment Captures the Largest Market Share and is Expected to Retain its Dominance over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Australia & New Zealand Medical Imaging Services Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Modality
- 5.1.1. MRI
- 5.1.2. Computed Tomography
- 5.1.3. Ultrasound
- 5.1.4. X-ray
- 5.1.5. Nuclear Imaging
- 5.1.6. Fluoroscopy
- 5.1.7. Mamography
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Cardiology
- 5.2.2. Oncology
- 5.2.3. Neurology
- 5.2.4. Orthopedics
- 5.2.5. Gastroenterology
- 5.2.6. Gynecology
- 5.2.7. Other Applications
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Hospital
- 5.3.2. Diagnostic Centers
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. Australia
- 5.1. Market Analysis, Insights and Forecast - by Modality
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Hologic Inc
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 GE Healthcare
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Esaote
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Canon Medical Systems Ltd
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Siemens Healthcare GmbH*List Not Exhaustive
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Carestream Health
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Koninklijke Philips NV
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Fujifilm Holdings Corporation
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.1 Hologic Inc
List of Figures
- Figure 1: Australia & New Zealand Medical Imaging Services Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Australia & New Zealand Medical Imaging Services Industry Share (%) by Company 2024
List of Tables
- Table 1: Australia & New Zealand Medical Imaging Services Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Australia & New Zealand Medical Imaging Services Industry Revenue Million Forecast, by Modality 2019 & 2032
- Table 3: Australia & New Zealand Medical Imaging Services Industry Revenue Million Forecast, by Application 2019 & 2032
- Table 4: Australia & New Zealand Medical Imaging Services Industry Revenue Million Forecast, by End User 2019 & 2032
- Table 5: Australia & New Zealand Medical Imaging Services Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 6: Australia & New Zealand Medical Imaging Services Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 7: Australia & New Zealand Medical Imaging Services Industry Revenue Million Forecast, by Modality 2019 & 2032
- Table 8: Australia & New Zealand Medical Imaging Services Industry Revenue Million Forecast, by Application 2019 & 2032
- Table 9: Australia & New Zealand Medical Imaging Services Industry Revenue Million Forecast, by End User 2019 & 2032
- Table 10: Australia & New Zealand Medical Imaging Services Industry Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Australia & New Zealand Medical Imaging Services Industry?
The projected CAGR is approximately 6.11%.
2. Which companies are prominent players in the Australia & New Zealand Medical Imaging Services Industry?
Key companies in the market include Hologic Inc, GE Healthcare, Esaote, Canon Medical Systems Ltd, Siemens Healthcare GmbH*List Not Exhaustive, Carestream Health, Koninklijke Philips NV, Fujifilm Holdings Corporation.
3. What are the main segments of the Australia & New Zealand Medical Imaging Services Industry?
The market segments include Modality, Application, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Technological Advancements; Growth Burden of Chronic Diseases.
6. What are the notable trends driving market growth?
X-ray Segment Captures the Largest Market Share and is Expected to Retain its Dominance over the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Advanced Diagnostic Imaging Devices.
8. Can you provide examples of recent developments in the market?
In May 2022, The Australian medical technology company EMVision has developed portable brain imaging technology.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Australia & New Zealand Medical Imaging Services Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Australia & New Zealand Medical Imaging Services Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Australia & New Zealand Medical Imaging Services Industry?
To stay informed about further developments, trends, and reports in the Australia & New Zealand Medical Imaging Services Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence